GlassScriptPhysician profile
John Taylor Mansfield
NPI 1689109233
$25,372.85
in general payments reported to CMS, 2019-2025
18 companies · $14K in 2025
The $14K reported for 2025 was more than what 95% of Interventional Pain Medicine providers received nationally (typical 2025 total: $676).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $185 · 2022: $3,426 · 2023: $4,151 · 2024: $3,743 · 2025: $14K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $7,083 · Food and Beverage: $5,329 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $5,100 · Consulting Fee: $4,250.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $7,083.13 |
| Food and Beverage | $5,329.14 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $5,100.00 |
| Consulting Fee | $4,250.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $14,242.73 | 2021-2025 | Wavewriter Alpha Prime 16, General - Therapies, Accolade Sr |
| Medtronic, INC. | $4,377.95 | 2022-2025 | Intellis Adaptivestim, Vanta Adaptivestim, Kyphon Express II Kyphopak Tray |
| Spinal Simplicity, LLC | $3,646.21 | 2022-2025 | Ha Minuteman G3-R, Liberty Si, Patriot Si |
| Relievant Medsystems, INC. | $807.65 | 2022-2023 | Intracept |
| Nevro Corp. | $708.80 | 2022-2024 | Senza |
| Abbott Laboratories | $702.96 | 2023-2025 | Proclaim, Octrode, Eterna |
| Collegium Pharmaceutical, INC. | $233.24 | 2022-2025 | Belbuca, Xtampza |
| Globus Medical, INC. | $183.62 | 2025 | Senza |
| Mml US, INC. | $141.40 | 2023-2025 | Reactiv8 |
| Spr Therapeutics, INC | $102.04 | 2022-2025 | Sprint Pns System |
| Vertos Medical, INC. | $93.22 | 2024 | Mild Device Kit |
| Metacel Pharmaceuticals LLC | $28.34 | 2025 | Ozobax |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $20.34 | 2022 | |
| Saluda Medical Americas, INC. | $17.23 | 2024 | Evoke |
| Tersera Therapeutics LLC | $17.18 | 2023 | Prialt |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Curonix LLC | $16.89 | 2025 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Painteq LLC | $16.54 | 2023 | Painteq |
| Scilex Pharmaceuticals INC. | $16.51 | 2023 | Ztlido |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Mansfield listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.